Ruvin Orbach
Speaking & Media
Conversations on biotechnology, investment, innovation and bringing promising ideas forward.
Ruvin Orbach is available for select speaking and media opportunities, including podcast interviews, media conversations, conference presentations, webinars and panel discussions focused on biotechnology, cellular immunotherapy, entrepreneurship, investment and strategic partnerships.
Invite Ruvin Orbach for Speaking & Media
Podcast Interviews
Thoughtful conversations on biotech, innovation and entrepreneurship.
Panel Discussions
Executive perspectives on biotechnology, investment and emerging healthcare.
Media Interviews
Commentary on biotech trends, cancer vaccines and strategic partnerships.
Speaking Engagements
Insights for conferences, webinars and industry events.
Suggested Topics
- The renewed momentum behind therapeutic cancer vaccines
- What investors should understand about biotechnology and immunotherapy
- Moving promising science from discovery toward clinical development
- Why strategic partnerships matter as much as capital in biotechnology
- The growing role of family offices in life sciences investment
- Entrepreneurship, company building and emerging healthcare technologies
Industry Conversations
.png)
Ruvin participates in conversations with biotechnology executives, investors, scientists and healthcare leaders about innovation, investment and the partnerships required to move emerging technologies forward.
About Ruvin
Ruvin Orbach is a biotechnology executive, investor and entrepreneur whose work spans healthcare innovation, strategic partnerships, investment and company building. He is the Founder of CellxLife, where he focuses on advancing cellular immunotherapies and therapeutic cancer vaccines.
His broader interests include emerging biotechnology, entrepreneurship, investment strategy and connecting promising ideas with the people, capital and partnerships needed to move them forward.